查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1361737

全球研究抗體和試劑市場報告

Global Research Antibodies & Reagents Market Report
出版日期: | 出版商: Value Market Research | 英文 310 Pages | 商品交期: 最快1-2個工作天內

價格

全球研究抗體和試劑市場的需求預計將從 2022 年的 140.1 億美元增至 2030 年的近 299.8 億美元，2023-2030 年研究期間年複合成長率為 8.82%。

研究抗體和試劑通常用於檢測未綴合的一抗，一抗進一步用於標靶抗原。研究抗體和試劑產品有助於在流式細胞儀、ELISA、免疫組織化學等不同應用中檢測、測量和純化蛋白質或生物分子。

市場動態：

為了研究再現性而對高品質抗體的需求增加是推動研究抗體和試劑市場成長的主要因素之一。此外，醫療健康研發投資的增加預計將推動研究抗體和試劑市場的成長。生物科學和生物技術在醫療保健和製藥領域不斷成長的應用正在推動需求。此外，生命科學產業投資的增加正在推動對研究抗體和試劑的需求。此外，產學界合作的增加以及幹細胞和神經生物學研究領域的興起進一步影響了研究抗體和試劑市場。然而，與識別和開發潛在抗體相關的高成本和時間預計將阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球研究抗體和試劑市場的各個細分市場進行了包容性評估。研究抗體和試劑行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲研究抗體和試劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。研究抗體和試劑市場的主要參與者包括 Thermo Fisher Scientific, Inc.（美國）、Merck KGaA（德國）、Abcam plc（英國）、Becton、Dickinson, and Company（美國）、Bio-Rad Laboratories（美國） 、 Cell Signaling Technology（美國）、F. Hoffmann-La Roche（瑞士）、Danaher Corporation（美國）、Agilent Technologies（美國）、PerkinElmer（美國）、Lonza（瑞士）、GenScript（中國）和BioLegend（美國） 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：研究抗體和試劑 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按形式分類的市場吸引力分析
    • 按來源分類的市場吸引力分析
    • 按研究領域分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球研究抗體與試劑市場銷售：按產品分類

  • 按產品概述
  • 歷史和預測銷售數據
  • 按產品分析
  • 試劑
  • 媒體與血清
  • 污漬和染料
  • 固定劑
  • 緩衝器
  • 溶劑
  • 酵素
  • 探頭
  • 其他試劑
  • 抗體

第 7 章：全球研究抗體與試劑市場分析：按類型

  • 按類型概述
  • 歷史和預測銷售數據
  • 按類型分析
  • 一抗
  • 二抗

第 8 章：全球研究抗體與試劑市場分析：依形式

  • 表格概述
  • 歷史和預測銷售數據
  • 形式分析
  • 單複製
  • 多克隆
  • 重組

第 9 章：全球研究抗體與試劑市場分析：依來源分類

  • 按來源概述
  • 歷史和預測銷售數據
  • 按來源分析
  • 老鼠
  • 兔子
  • 其他來源

第 10 章：全球研究抗體與試劑市場分析：按研究領域

  • 研究領域概述
  • 歷史和預測銷售數據
  • 按研究領域分析
  • 腫瘤學
  • 傳染性疾病
  • 免疫學
  • 神經生物學
  • 幹細胞
  • 其他研究領域

第 11 章：全球研究抗體和試劑市場分析：按技術分類

  • 依技術概述
  • 歷史和預測銷售數據
  • 依技術分析
  • 蛋白質印跡法
  • 流式細胞儀
  • 酵素連結免疫吸附測定法 (ELISA)
  • 免疫組織化學
  • 免疫螢光
  • 免疫沉澱
  • 其他技術

第 12 章：全球研究抗體和試劑市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測銷售數據
  • 分析：按應用
  • 蛋白質體學
  • 藥物開發
  • 基因組學

第 13 章：全球研究抗體和試劑市場分析：按最終用戶

  • 最終用戶概述
  • 歷史和預測銷售數據
  • 最終用戶分析
  • 製藥與生物技術產業
  • 學術研究機構
  • 合約研究組織

第 14 章：全球研究抗體和試劑市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 15 章：研究抗體和試劑公司的競爭格局

  • 研究抗體和試劑市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 16 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Thermo Fisher Scientific Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abcam plc (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Becton
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dickinson and Company (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cell Signaling Technology (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche (Switzerland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Agilent Technologies (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • PerkinElmer (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lonza (Switzerland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GenScript (China)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioLegend (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11218746

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 29.98 BN by 2030 from USD 14.01 BN in 2022 with a CAGR of 8.82% under the study period 2023 - 2030.

Research antibodies & reagents are generally utilized to detect an unconjugated primary antibody which is further used to target antigen. Research antibodies & reagent products assist in detecting, measuring and purifying proteins or biomolecules in different applications such as flow cytometry, ELISA, immunohistochemistry and more.

MARKET DYNAMICS:

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of research antibodies & reagents. The growth and trends of research antibodies & reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the research antibodies & reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagent
  • Media & Sera
  • Stains & Dyes
  • Fixatives
  • Buffers
  • Solvents
  • Enzymes
  • Probes
  • Other Reagents
  • Antibodies

By Type

  • Primary Antibodies
  • Secondary Antibodies

By Form

  • Monoclonal
  • Polyclonal
  • Recombinant

By Source

  • Mice
  • Rabbits
  • Other Sources

By Research Area

  • Oncology
  • Infectious Diseases
  • Immunology
  • Neurobiology
  • Stem Cells
  • Other Research Areas

By Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (Elisa)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

By Application

  • Proteomics
  • Drug Development
  • Genomics

By End User

  • Pharmaceutical & Biotechnologies Industries
  • Academic & Research Institutions
  • Contract Research Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the research antibodies & reagents market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Form
    • 3.7.4 Market Attractiveness Analysis By Source
    • 3.7.5 Market Attractiveness Analysis By Research Area
    • 3.7.6 Market Attractiveness Analysis By Technology
    • 3.7.7 Market Attractiveness Analysis By Application
    • 3.7.8 Market Attractiveness Analysis By End User
    • 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Sales Data
  • 6.3 Analysis by Product
  • 6.4 Reagent Historic and Forecast Sales by Regions
  • 6.5 Media & Sera Historic and Forecast Sales by Regions
  • 6.6 Stains & Dyes Historic and Forecast Sales by Regions
  • 6.7 Fixatives Historic and Forecast Sales by Regions
  • 6.8 Buffers Historic and Forecast Sales by Regions
  • 6.9 Solvents Historic and Forecast Sales by Regions
  • 6.10. Enzymes Historic and Forecast Sales by Regions
  • 6.11 Probes Historic and Forecast Sales by Regions
  • 6.12 Other Reagents Historic and Forecast Sales by Regions
  • 6.13 Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Sales Data
  • 7.3 Analysis by Type
  • 7.4 Primary Antibodies Historic and Forecast Sales by Regions
  • 7.5 Secondary Antibodies Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

  • 8.1 Overview by Form
  • 8.2 Historical and Forecast Sales Data
  • 8.3 Analysis by Form
  • 8.4 Monoclonal Historic and Forecast Sales by Regions
  • 8.5 Polyclonal Historic and Forecast Sales by Regions
  • 8.6 Recombinant Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

  • 9.1 Overview by Source
  • 9.2 Historical and Forecast Sales Data
  • 9.3 Analysis by Source
  • 9.4 Mice Historic and Forecast Sales by Regions
  • 9.5 Rabbits Historic and Forecast Sales by Regions
  • 9.6 Other Sources Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

  • 10.1 Overview by Research Area
  • 10.2 Historical and Forecast Sales Data
  • 10.3 Analysis by Research Area
  • 10.4 Oncology Historic and Forecast Sales by Regions
  • 10.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 10.6 Immunology Historic and Forecast Sales by Regions
  • 10.7 Neurobiology Historic and Forecast Sales by Regions
  • 10.8 Stem Cells Historic and Forecast Sales by Regions
  • 10.9 Other Research Areas Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

  • 11.1 Overview by Technology
  • 11.2 Historical and Forecast Sales Data
  • 11.3 Analysis by Technology
  • 11.4 Western Blotting Historic and Forecast Sales by Regions
  • 11.5 Flow Cytometry Historic and Forecast Sales by Regions
  • 11.6 Enzyme-linked Immunosorbent Assay (ELISA) Historic and Forecast Sales by Regions
  • 11.7 Immunohistochemistry Historic and Forecast Sales by Regions
  • 11.8 Immunofluorescence Historic and Forecast Sales by Regions
  • 11.9 Immunoprecipitation Historic and Forecast Sales by Regions
  • 11.1 Other Technologies Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

  • 12.1 Overview by Application
  • 12.2 Historical and Forecast Sales Data
  • 12.3 Analysis by Application
  • 12.4 Proteomics Historic and Forecast Sales by Regions
  • 12.5 Drug Development Historic and Forecast Sales by Regions
  • 12.6 Genomics Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY END USER

  • 13.1 Overview by End User
  • 13.2 Historical and Forecast Sales Data
  • 13.3 Analysis by End User
  • 13.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
  • 13.5 Academic & Research Institutions Historic and Forecast Sales by Regions
  • 13.6 Contract Research Organizations Historic and Forecast Sales by Regions

14 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 14.1. Regional Outlook
  • 14.2. Introduction
  • 14.3. North America Sales Analysis
    • 14.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.3.2. North America By Segment Sales Analysis
    • 14.3.3. North America By Country Sales Analysis
    • 14.3.4. United State Sales Analysis
    • 14.3.5. Canada Sales Analysis
    • 14.3.6. Mexico Sales Analysis
  • 14.4. Europe Sales Analysis
    • 14.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.4.2. Europe by Segment Sales Analysis
    • 14.4.3. Europe by Country Sales Analysis
    • 14.4.4. United Kingdom Sales Analysis
    • 14.4.5. France Sales Analysis
    • 14.4.6. Germany Sales Analysis
    • 14.4.7. Italy Sales Analysis
    • 14.4.8. Russia Sales Analysis
    • 14.4.9. Rest Of Europe Sales Analysis
  • 14.5. Asia Pacific Sales Analysis
    • 14.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.5.2. Asia Pacific by Segment Sales Analysis
    • 14.5.3. Asia Pacific by Country Sales Analysis
    • 14.5.4. China Sales Analysis
    • 14.5.5. India Sales Analysis
    • 14.5.6. Japan Sales Analysis
    • 14.5.7. South Korea Sales Analysis
    • 14.5.8. Australia Sales Analysis
    • 14.5.9. Rest Of Asia Pacific Sales Analysis
  • 14.6. Latin America Sales Analysis
    • 14.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.6.2. Latin America by Segment Sales Analysis
    • 14.6.3. Latin America by Country Sales Analysis
    • 14.6.4. Brazil Sales Analysis
    • 14.6.5. Argentina Sales Analysis
    • 14.6.6. Peru Sales Analysis
    • 14.6.7. Chile Sales Analysis
    • 14.6.8. Rest of Latin America Sales Analysis
  • 14.7. Middle East & Africa Sales Analysis
    • 14.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 14.7.2. Middle East & Africa by Segment Sales Analysis
    • 14.7.3. Middle East & Africa by Country Sales Analysis
    • 14.7.4. Saudi Arabia Sales Analysis
    • 14.7.5. UAE Sales Analysis
    • 14.7.6. Israel Sales Analysis
    • 14.7.7. South Africa Sales Analysis
    • 14.7.8. Rest Of Middle East And Africa Sales Analysis

15 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

  • 15.1. Research Antibodies & Reagents Market Competition
  • 15.2. Partnership/Collaboration/Agreement
  • 15.3. Merger And Acquisitions
  • 15.4. New Product Launch
  • 15.5. Other Developments

16 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

  • 16.1. Company Share Analysis
  • 16.2. Market Concentration Rate
  • 16.3. Thermo Fisher Scientific Inc. (US)
    • 16.3.1. Company Overview
    • 16.3.2. Company Revenue
    • 16.3.3. Products
    • 16.3.4. Recent Developments
  • 16.4. Merck KGaA (Germany)
    • 16.4.1. Company Overview
    • 16.4.2. Company Revenue
    • 16.4.3. Products
    • 16.4.4. Recent Developments
  • 16.5. Abcam plc (UK)
    • 16.5.1. Company Overview
    • 16.5.2. Company Revenue
    • 16.5.3. Products
    • 16.5.4. Recent Developments
  • 16.6. Becton
    • 16.6.1. Company Overview
    • 16.6.2. Company Revenue
    • 16.6.3. Products
    • 16.6.4. Recent Developments
  • 16.7. Dickinson and Company (US)
    • 16.7.1. Company Overview
    • 16.7.2. Company Revenue
    • 16.7.3. Products
    • 16.7.4. Recent Developments
  • 16.8. Bio-Rad Laboratories (US)
    • 16.8.1. Company Overview
    • 16.8.2. Company Revenue
    • 16.8.3. Products
    • 16.8.4. Recent Developments
  • 16.9. Cell Signaling Technology (US)
    • 16.9.1. Company Overview
    • 16.9.2. Company Revenue
    • 16.9.3. Products
    • 16.9.4. Recent Developments
  • 16.10. F. Hoffmann-La Roche (Switzerland)
    • 16.10.1. Company Overview
    • 16.10.2. Company Revenue
    • 16.10.3. Products
    • 16.10.4. Recent Developments
  • 16.11. Danaher Corporation (US)
    • 16.11.1. Company Overview
    • 16.11.2. Company Revenue
    • 16.11.3. Products
    • 16.11.4. Recent Developments
  • 16.12. Agilent Technologies (US)
    • 16.12.1. Company Overview
    • 16.12.2. Company Revenue
    • 16.12.3. Products
    • 16.12.4. Recent Developments
  • 16.13. PerkinElmer (US)
    • 16.13.1. Company Overview
    • 16.13.2. Company Revenue
    • 16.13.3. Products
    • 16.13.4. Recent Developments
  • 16.14. Lonza (Switzerland)
    • 16.14.1. Company Overview
    • 16.14.2. Company Revenue
    • 16.14.3. Products
    • 16.14.4. Recent Developments
  • 16.15. GenScript (China)
    • 16.15.1. Company Overview
    • 16.15.2. Company Revenue
    • 16.15.3. Products
    • 16.15.4. Recent Developments
  • 16.16. BioLegend (US)
    • 16.16.1. Company Overview
    • 16.16.2. Company Revenue
    • 16.16.3. Products
    • 16.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Reagent Market Sales by Geography (USD MN)
  • Media & Sera Market Sales by Geography (USD MN)
  • Stains & Dyes Market Sales by Geography (USD MN)
  • Fixatives Market Sales by Geography (USD MN)
  • Buffers Market Sales by Geography (USD MN)
  • Solvents Market Sales by Geography (USD MN)
  • Enzymes Market Sales by Geography (USD MN)
  • Probes Market Sales by Geography (USD MN)
  • Other Reagents Market Sales by Geography (USD MN)
  • Antibodies Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Primary Antibodies Market Sales by Geography (USD MN)
  • Secondary Antibodies Market Sales by Geography (USD MN)
  • Analysis by Form (USD MN)
  • Monoclonal Market Sales by Geography (USD MN)
  • Polyclonal Market Sales by Geography (USD MN)
  • Recombinant Market Sales by Geography (USD MN)
  • Analysis by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rabbits Market Sales by Geography (USD MN)
  • Other Sources Market Sales by Geography (USD MN)
  • Analysis by Research Area (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Immunology Market Sales by Geography (USD MN)
  • Neurobiology Market Sales by Geography (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Other Research Areas Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Western Blotting Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Enzyme-linked Immunosorbent Assay (ELISA) Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Immunofluorescence Market Sales by Geography (USD MN)
  • Immunoprecipitation Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Proteomics Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Genomics Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutions Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global Research Antibodies & Reagents Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Research Antibodies & Reagents Report
  • Market Research Process
  • Market Research Methodology
  • Global Research Antibodies & Reagents Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Form
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by Research Area
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Reagent Market Sales by Geography (USD MN)
  • Media & Sera Market Sales by Geography (USD MN)
  • Stains & Dyes Market Sales by Geography (USD MN)
  • Fixatives Market Sales by Geography (USD MN)
  • Buffers Market Sales by Geography (USD MN)
  • Solvents Market Sales by Geography (USD MN)
  • Enzymes Market Sales by Geography (USD MN)
  • Probes Market Sales by Geography (USD MN)
  • Other Reagents Market Sales by Geography (USD MN)
  • Antibodies Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Primary Antibodies Market Sales by Geography (USD MN)
  • Secondary Antibodies Market Sales by Geography (USD MN)
  • Global Market Analysis by Form (USD MN)
  • Monoclonal Market Sales by Geography (USD MN)
  • Polyclonal Market Sales by Geography (USD MN)
  • Recombinant Market Sales by Geography (USD MN)
  • Global Market Analysis by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rabbits Market Sales by Geography (USD MN)
  • Other Sources Market Sales by Geography (USD MN)
  • Global Market Analysis by Research Area (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Immunology Market Sales by Geography (USD MN)
  • Neurobiology Market Sales by Geography (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Other Research Areas Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Western Blotting Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Enzyme-linked Immunosorbent Assay (ELISA) Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Immunofluorescence Market Sales by Geography (USD MN)
  • Immunoprecipitation Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Proteomics Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Genomics Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnologies Industries Market Sales by Geography (USD MN)
  • Academic & Research Institutions Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.